1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective
of the Study
2.2. Baseline
Methodology
2.3. Key
Industry Partners
2.4. Major
Association and Secondary Sources
2.5. Forecasting
Methodology
2.6. Data
Triangulation & Validation
2.7. Assumptions
and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5.
Global Invasive
Fungal Infection Market Outlook
5.1. Market Size & Forecast
5.1.1.
By Value
5.2. Market Share & Forecast
5.2.1.
By Disease Type
(Candidaemi Caa and Invasive Candiasis, Intra-abdominal Candiasis, Cryptococcal
Meningitis, Esophageal Candidiasis, Histoplasmosis Acute Pulmonary, Others)
5.2.2.
By Drug Type
(Polyenes, Amphotericin B Deoxycholate, Lipid Formulation Amphotericin B,
Others)
5.2.3.
By Region
5.2.4.
By Company (2022)
5.3. Market Map
6.
Asia Pacific Invasive
Fungal Infection Market Outlook
6.1. Market Size & Forecast
6.1.1.
By Value
6.2. Market Share & Forecast
6.2.1.
By Disease Type
6.2.2.
By Drug Type
6.2.3.
By Country
6.3. Asia Pacific: Country Analysis
6.3.1.
China Invasive Fungal
Infection Market Outlook
6.3.1.1.
Market Size & Forecast
6.3.1.1.1.
By Value
6.3.1.2.
Market Share & Forecast
6.3.1.2.1.
By Disease Type
6.3.1.2.2.
By Drug Type
6.3.2.
India Invasive
Fungal Infection Market Outlook
6.3.2.1.
Market Size & Forecast
6.3.2.1.1.
By Value
6.3.2.2.
Market Share & Forecast
6.3.2.2.1.
By Disease Type
6.3.2.2.2.
By Drug Type
6.3.3.
Australia Invasive
Fungal Infection Market Outlook
6.3.3.1.
Market Size & Forecast
6.3.3.1.1.
By Value
6.3.3.2.
Market Share & Forecast
6.3.3.2.1.
By Disease Type
6.3.3.2.2.
By Drug Type
6.3.4.
Japan Invasive
Fungal Infection Market Outlook
6.3.4.1.
Market Size & Forecast
6.3.4.1.1.
By Value
6.3.4.2.
Market Share & Forecast
6.3.4.2.1.
By Disease Type
6.3.4.2.2.
By Drug Type
6.3.5.
South Korea Invasive
Fungal Infection Market Outlook
6.3.5.1.
Market Size & Forecast
6.3.5.1.1.
By Value
6.3.5.2.
Market Share & Forecast
6.3.5.2.1.
By Disease Type
6.3.5.2.2.
By Drug Type
7.
Europe Invasive
Fungal Infection Market Outlook
7.1. Market Size & Forecast
7.1.1.
By Value
7.2. Market Share & Forecast
7.2.1.
By Disease Type
7.2.2.
By Drug Type
7.2.3.
By Country
7.3. Europe: Country Analysis
7.3.1.
France Invasive
Fungal Infection Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Disease Type
7.3.1.2.2.
By Drug Type
7.3.2.
Germany Invasive
Fungal Infection Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Disease Type
7.3.2.2.2.
By Drug Type
7.3.3.
Spain Invasive
Fungal Infection Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Disease Type
7.3.3.2.2.
By Drug Type
7.3.4.
Italy Invasive
Fungal Infection Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Disease Type
7.3.4.2.2.
By Drug Type
7.3.5.
United Kingdom Invasive
Fungal Infection Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Disease Type
7.3.5.2.2.
By Drug Type
8.
North America Invasive
Fungal Infection Market Outlook
8.1. Market Size & Forecast
8.1.1.
By Value
8.2. Market Share & Forecast
8.2.1.
By Disease Type
8.2.2.
By Drug Type
8.2.3.
By Country
8.3. North America: Country Analysis
8.3.1.
United States Invasive
Fungal Infection Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Disease Type
8.3.1.2.2.
By Drug Type
8.3.2.
Mexico Invasive
Fungal Infection Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Disease Type
8.3.2.2.2.
By Drug Type
8.3.3.
Canada Invasive
Fungal Infection Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Disease Type
8.3.3.2.2.
By Drug Type
9.
South America Invasive
Fungal Infection Market Outlook
9.1. Market Size & Forecast
9.1.1.
By Value
9.2. Market Share & Forecast
9.2.1.
By Disease Type
9.2.2.
By Drug Type
9.2.3.
By Country
9.3. South America: Country Analysis
9.3.1.
Brazil Invasive
Fungal Infection Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Disease Type
9.3.1.2.2.
By Drug Type
9.3.2.
Argentina Invasive
Fungal Infection Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Disease Type
9.3.2.2.2.
By Drug Type
9.3.3.
Colombia Invasive
Fungal Infection Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Disease Type
9.3.3.2.2.
By Drug Type
10.
Middle East and Africa
Invasive Fungal Infection Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1.
By Disease Type
10.2.2.
By Drug Type
10.2.3. By Country
10.3.
MEA: Country
Analysis
10.3.1. South Africa Invasive Fungal Infection Market Outlook
10.3.1.1. Market Size &
Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share &
Forecast
10.3.1.2.1.
By Disease Type
10.3.1.2.2.
By Drug Type
10.3.2. Saudi Arabia Invasive Fungal Infection Market Outlook
10.3.2.1. Market Size &
Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share &
Forecast
10.3.2.2.1.
By Disease Type
10.3.2.2.2.
By Drug Type
10.3.3. UAE Invasive Fungal Infection Market Outlook
10.3.3.1. Market Size &
Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Disease Type
10.3.3.2.2.
By Drug Type
11. Market Dynamics
11.1.
Drivers
11.2.
Challenges
12. Market Trends & Developments
12.1.
Recent Developments
12.2.
Product Launches
12.3.
Mergers &
Acquisitions
13. Global Invasive Fungal Infection Market: SWOT Analysis
14.
Porter’s Five Forces
Analysis
14.1.
Competition in the
Industry
14.2.
Potential of New
Entrants
14.3.
Power of Suppliers
14.4.
Power of Customers
14.5.
Threat of Substitute
Product
15. PESTLE Analysis
16. Competitive Landscape
16.1.
Cidara Therapeutics,
Inc.
16.1.1. Business Overview
16.1.2. Company Snapshot
16.1.3. Products & Services
16.1.4. Financials (In case of listed companies)
16.1.5. Recent Developments
16.1.6. SWOT Analysis
16.2. Basilea Pharmaceutica AG Allschwil.
16.2.1. Business Overview
16.2.2. Company Snapshot
16.2.3. Products & Services
16.2.4. Financials (In case of listed companies)
16.2.5. Recent Developments
16.2.6. SWOT Analysis
16.3. Pfizer Inc.
16.3.1. Business Overview
16.3.2. Company Snapshot
16.3.3. Products & Services
16.3.4. Financials (In case of listed companies)
16.3.5. Recent Developments
16.3.6. SWOT Analysis
16.4.
GlaxoSmith Kline
Plc.
16.4.1. Business Overview
16.4.2. Company Snapshot
16.4.3. Products & Services
16.4.4. Financials (In case of listed companies)
16.4.5. Recent Developments
16.4.6. SWOT Analysis
16.5.
Bayer AG
16.5.1. Business Overview
16.5.2. Company Snapshot
16.5.3. Products & Services
16.5.4. Financials (In case of listed companies)
16.5.5. Recent Developments
16.5.6. SWOT Analysis
16.6.
Abbott laboratories Ltd.
16.6.1. Business Overview
16.6.2. Company Snapshot
16.6.3. Products & Services
16.6.4. Financials (In case of listed companies)
16.6.5. Recent Developments
16.6.6. SWOT Analysis
16.7.
Merck & Co, Inc.
16.7.1. Business Overview
16.7.2. Company Snapshot
16.7.3. Products & Services
16.7.4. Financials (In case of listed companies)
16.7.5. Recent Developments
16.7.6. SWOT Analysis
16.8.
Astellas Pharma Inc.
16.8.1. Business Overview
16.8.2. Company Snapshot
16.8.3. Products & Services
16.8.4. Financials (In case of listed companies)
16.8.5. Recent Developments
16.8.6. SWOT Analysis
16.9.
Scynexis Inc.
16.9.1. Business Overview
16.9.2. Company Snapshot
16.9.3. Products & Services
16.9.4. Financials (In case of listed companies)
16.9.5. Recent Developments
16.9.6. SWOT Analysis
16.10.Matinas BioPharma Holdings, Inc
16.10.1. Business Overview
16.10.2. Company Snapshot
16.10.3. Products & Services
16.10.4. Financials (In case of listed companies)
16.10.5. Recent Developments
16.10.6. SWOT Analysis
17.
Strategic Recommendations
18.
About Us &
Disclaimer